McKesson Investor Attys Get $35M For $141M Price Fix Deal

By Henrik Nilsson

Robbins Geller Rudman & Dowd LLP attorneys who represent a class of
McKesson investors will receive $35 million in fees from a $141 million
settlement for their work on litigation alleging the company made false
assertions concerning a drug price-fixing scheme, according to an order
issued in California federal court on Friday.

 2 documents attached | Read full article » | Save to favorites »


https://www.law360.com/competition/articles/1700069?nl_pk=2063be2d-1a29-43b6-9ead-82226ec9fd97&utm_source=newsletter&utm_medium=email&utm_campaign=competition&utm_content=2023-07-17&read_main=1&nlsidx=0&nlaidx=6

Reply via email to